Tilray: Federal Rescheduling Of Cannabis May Ignite Sector Rally

Tilray's stock recently underwent a 1:10 reverse split, and President Trump signed an EO to reschedule cannabis to Schedule ...
The Motley Fool

Here's Why Tilray Brands Has Become a Much Better Buy Than Canopy Growth

Tilray Brands has been expanding while also making progress on its bottom line. Canopy Growth's strategy centers around hopes for cannabis legalization in the U.S. The company has even created a ...

What's Next After A 3.5X Surge In Tilray Stock?

By December 2025, however, the stock had surged roughly 3.5 times (or more) from mid-year levels — a remarkable rebound in a ...
Seeking Alpha

Tilray Should Be Cut From Your Portfolio

Tilray's stock price has fallen 18.3% in 2024, lagging behind the market and its peers. Tilray's Q3 report showed slow growth, declining adjusted EBITDA, and a troubled balance sheet with high ...
The Motley Fool

Tilray Brands Is Buying More Beer Brands, and Its Wheeling and Dealing Isn't Over

Its beverage business was the biggest source of revenue for Tilray last quarter. The company's CEO says it's still not done with acquisitions. Expanding into alcohol has helped Tilray grow its ...

Option Traders Are Pricing a Nearly 22% Move in Tilray Stock Before the End of 2025. Should You Buy, Sell, or Hold TLRY Here?

Tilray stock soared today after President Donald Trump signalled reclassification of cannabis as a Schedule III drug in the ...
StockStory.org on MSN

Why Tilray (TLRY) Shares Are Falling Today

Shares of cannabis company Tilray Brands (NASDAQ:TLRY) fell 5.2% in the afternoon session after the stock gave back some of ...